I recommend that we introduce the medical products into the Chinese market instead of U.K. China has been facing a rapid increase in disease burden in recent years with improved urbanization, growing household incomes, and rising aging levels that pose a significant health risk to its citizens. Consequently, China now faces a considerable challenge regarding increased blood pressure cases, unchecked tobacco use, and poor diet (Yang et al. 1987). However, unlike the Asian nations, European countries have better health strategies that make them less vulnerable to communicable diseases when compared to Asian states.
For instance, 87% of the European population can access improved sanitation facilities, compared to Asian 15% of the people that enjoy similar health requirements (Pruss-Ustun et al. 7). Indeed, with these conditions, China proves a more lucrative market for medical products than the U.K. due to their increased health risks.
Air pollution levels in China have reached a worrying trend. A notable example was observed in 2013 when over 1.6 million people died as a result of air pollution (Chen and Liao 387). Citizens who depend on coal for heating further worsen the situation. These practices contribute to terminal diseases such as the prolonged obstructive respiratory illness. In the U.K., however, the effects of air pollution are lower than that of China. According to Roberts, the annual deaths attributed to air pollution in the U.K. have been 40,000. These figures mean that the effects of air pollution are worse in China than they are in the U.K. Consequently, given that polluted environments contribute to many health problems, China seems to experience many diseases as a result of their environmental pollution. It is, thus, reasonable to enter the Chinese market instead of the U.K. due to a possible difference in demand for medical products required to manage the diseases.
The entry mode to the Chinese market should be efficient and practical. In this case, the export mode should be embraced. According to Samiee, the strategy is always fast, efficient, and presents low risks to a business enterprise (659). The mode will enable the company to export its products to China without having to establish its operations there. For a start, the firm will continue to produce its innovative medical products locally without the need to transfer its production facilities to the new market. Such benefits will enable the company to minimize its cost of operations, thus, increase its profitability.
The Chinese market, consequently, offers the most promising growth and profitability opportunities than the U.K. Numerous health risks and challenges prevalent in China calls for possible high demand for medical products, while few health problems in the U.K. may not require increased interventions. Likewise, the export entry mode may be best suited for the Chinese market due to possible uncertainties during the entry. Undeniably, the choices are the most viable for growth and profitability.
Works Cited
Chen, Tianqi, and Hua Liao. "The Disease Burden of Indoor air Pollution from Solid Fuel use in China." Asia Pacific Journal of Public Health, vol. 30, no. 4, 2018, pp. 387-395.
Pruss-Ustun, Annette et al. "Burden of Disease from Inadequate Water, Sanitation and Hygiene in Low- And Middle-Income Settings: A Retrospective Analysis of Data from 145 Countries." Tropical Medicine " International Health, vol. 19, no. 8, 2014, pp. 894-905.
Roberts, Michelle. "UK air Pollution 'Linked to 40,000 Early Deaths a Year'." BBC News, 23 Feb. 2016, www.bbc.com/news/health-35629034. Accessed 3 Aug. 2018.
Samiee, Saeed. "International Market-Entry Mode Decisions: Cultural Distance's Role in Classifying Partnerships versus Sole Ownership." Journal of Business Research, vol. 66, no. 5, 2013, pp. 659-661.
Yang, Gonghuan, et al. "Rapid Health Transition in China, 1990–2010: Findings from the Global Burden of Disease Study 2010." The Lancet, vol. 381, no. 9882, 2013, pp. 1987-2015, doi:10.1016/S0140-6736(13)61097-1.
